Digital twins: Tailoring medicine insilico

Digital Twins are established in other industries but are only now being incorporated into healthcare. They refer to virtual representations or simulations of real-world medical entities, processes, or systems. These digital replicas are created by collecting and integrating various data sources, such as medical records, patient data, and sensor data to model and simulate healthcare-related elements using advanced technology like artificial intelligence (AI) and machine learning (ML).

Join this exciting and unique event that will provide an introduction to digital twins and their potential for improving both personalised medicine and healthcare provision. It will explore how interventions are being tailored to the individual, how clinical trials could be transformed, what building a virtual human involves the implications for prevention and sustainability in healthcare and the regulatory and ethical questions posed by such technology. This is a unique opportunity for the RSM to host an event with thought leadership and pioneers, and lead the way in sharing options and considering how to manage potential risks of digital twins healthcare.

By attending this event, you will:

• Understand what digital twins could mean for clinical practice and pathways
• Review the regulatory pathways e.g. FDA, MHRA, MDU and explore the ethical considerations
• Examine where digital twins are in the research and provider landscape
• Learn from those involved in insilico trials
• Explore how digital twins could impact sustainability and healthcare accessibility for all sections of the population
• Hear a critique of the role of AI: explainability and limits, keeping it safe
• Discuss the way ahead